STAAR Surgical Co (STAA) income statement
STAANasdaqOphthalmic GoodsFiscal year ends January 2
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 3, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3067% above fair value
$25.35−0.21 (-0.82%)
Close on Nov 18, 2026Market cap $1.27BP/E 362.1Yield –
STAAR Surgical Co income statement
Ratios
Latest available, balances at Jul 3, 2026
Profitability, TTM
- Gross margin
- 76.6%
- Operating margin
- 4.0%
- Net margin
- 1.1%
- Return on equity, FY2025
- -21.7%
Financial strength
- Current ratio
- 4.66
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 202.4%
Valuation
- P/E ratio
- 362.1
- Price to sales
- 3.74
- Price to book
- 3.48
- Dividend yield
- –
See a number that looks wrong?